| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $48.47M | $114.70M | $0.00 | $0.00 | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $219.20M | $174.62M | $183.76M | $218.59M | $216.12M |
| R&D | $174.09M | $138.49M | $135.30M | $170.92M | $170.27M |
| SG&A | $37.63M | $36.13M | $38.45M | $47.61M | $45.78M |
| Operating Income | -$170.73M | -$59.92M | -$183.76M | -$218.59M | -$216.12M |
| Interest Expense | – | – | $13.51M | $13.88M | $19.44M |
| Tax Expense | -$88.00K | $893.00K | $0.00 | $0.00 | – |
| Net Income | -$170.37M | -$56.53M | -$179.82M | -$229.38M | -$234.00M |
| EPS (basic) | -0.7500 | -0.2500 | -1.1800 | -2.7100 | -3.1300 |
| EPS (diluted) | -0.7500 | -0.2500 | -1.1800 | -2.7100 | -3.1300 |
| Shares (diluted) | $228.52M | $226.23M | $152.62M | $84.57M | $74.84M |